Monaco Asset Management SAM Invests $1.22 Million in Teladoc Health, Inc. (NYSE:TDOC)

Monaco Asset Management SAM bought a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 125,000 shares of the health services provider's stock, valued at approximately $1,222,000. Monaco Asset Management SAM owned 0.07% of Teladoc Health as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in Teladoc Health by 11.8% in the fourth quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider's stock worth $377,451,000 after buying an additional 1,855,480 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Teladoc Health by 25.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider's stock valued at $82,636,000 after purchasing an additional 767,999 shares during the period. Norges Bank bought a new stake in shares of Teladoc Health during the fourth quarter valued at approximately $9,714,000. Pale Fire Capital SE purchased a new stake in Teladoc Health in the fourth quarter worth $8,960,000. Finally, Mizuho Markets Americas LLC bought a new position in Teladoc Health in the second quarter worth $3,937,000. Institutional investors own 76.82% of the company's stock.

Insider Activity

In related news, insider Vidya Raman-Tangella sold 3,857 shares of the firm's stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $8.14, for a total value of $31,395.98. Following the transaction, the insider now owns 33,667 shares of the company's stock, valued at $274,049.38. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, insider Vidya Raman-Tangella sold 3,857 shares of the firm's stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $31,395.98. Following the transaction, the insider now directly owns 33,667 shares of the company's stock, valued at approximately $274,049.38. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Michael Willem Waters sold 6,053 shares of the business's stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $8.14, for a total value of $49,271.42. Following the sale, the chief operating officer now directly owns 74,214 shares of the company's stock, valued at approximately $604,101.96. The disclosure for this sale can be found here. Insiders sold 57,819 shares of company stock valued at $442,204 in the last quarter. 0.95% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of analysts have recently commented on the stock. Truist Financial dropped their target price on shares of Teladoc Health from $15.00 to $10.00 and set a "hold" rating on the stock in a report on Friday, August 2nd. Barclays cut their price objective on shares of Teladoc Health from $20.00 to $10.00 and set an "overweight" rating on the stock in a report on Thursday, August 1st. Cantor Fitzgerald reiterated an "overweight" rating and set a $10.00 target price on shares of Teladoc Health in a report on Tuesday, August 20th. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a research report on Thursday, August 1st. Finally, TD Cowen reduced their price objective on Teladoc Health from $15.00 to $9.00 and set a "hold" rating for the company in a research report on Thursday, August 1st. Fourteen research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $12.44.

Teladoc Health Stock Performance

NYSE:TDOC traded up $0.06 during trading hours on Tuesday, reaching $7.25. The company had a trading volume of 3,195,316 shares, compared to its average volume of 5,513,646. The firm has a market cap of $1.23 billion, a price-to-earnings ratio of -5.11 and a beta of 0.90. The company has a current ratio of 1.66, a quick ratio of 1.62 and a debt-to-equity ratio of 0.66. The firm's 50 day moving average price is $8.21 and its 200-day moving average price is $11.28. Teladoc Health, Inc. has a 52 week low of $6.76 and a 52 week high of $22.98.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.28) EPS for the quarter, topping the consensus estimate of ($0.36) by $0.08. The company had revenue of $642.44 million during the quarter, compared to analyst estimates of $649.34 million. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. On average, analysts forecast that Teladoc Health, Inc. will post -0.73 EPS for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.